Crossmark

Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers

Crossref DOI link: https://doi.org/10.1186/s13195-022-01004-9

Published Online: 2022-04-26

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zebhauser, Paul Theo

Berthele, Achim

Goldhardt, Oliver

Diehl-Schmid, Janine

Priller, Josef

Ortner, Marion

Grimmer, Timo
Funding

Funding for this research was provided by:

Technische Universität München
License Information

Text and Data Mining valid from 2022-04-26

Version of Record valid from 2022-04-26
More Information

Article History

Received: 20 December 2021

Accepted: 8 April 2022

First Online: 26 April 2022

Declarations

:

: The authors declare that they have no competing interests.

: For healthy controls, the study was approved by the ethics committee of the Technical University of Munich (TUM), Munich, Germany (project code: 29/17 S). For patients, no ethical approval was needed, as for those participants, a retrospective analysis of routinely collected clinical data was conducted. All study participants provided written informed consent for the use of clinical data for scientific purposes.

: Not applicable.

Document is current

Any future updates will be listed below